1. Introduction {#sec1}
===============

Ginseng has been used for over 2,000 y as a medicine in East Asia. It is a popular herb in the world, and is used in more than 35 countries as a food, health supplement, and natural remedy [@bib1]. Ginseng has been demonstrated to have an extensive range of pharmacological effects on the reproductive, cardiovascular, endocrine, and immune systems. Its ability to diminish fatigue, enhance blood circulation, aid menopausal symptoms, boost immune function, and enhance concentration has been verified in certain countries [@bib2]. Many components of ginseng, such as ginsenosides, polysaccharides, peptides, polyacetylenic alcohols, and fatty acids, have been isolated and characterized [@bib3], [@bib4]. However, further research is necessary to understand how these components contribute to ginseng\'s pharmacological properties. Among these constituents, dammarane-type ginsenosides, comprising a rigid steroid skeleton consisting of four transrings with a modified side chain at C--20, have received considerable attention because of their biological activity [@bib5], [@bib6]. To date, more than 100 different ginsenosides with various pharmacological effects have been isolated and identified from the root of *Panax ginseng*, with ginsenosides Rb1, Rb2, Rg1, and Re being most abundant. In addition, steaming and drying during processing of ginseng can affect its pharmacological activity by altering the characteristics of the constituent ginsenosides [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12]. Red ginseng, produced by steaming fresh ginseng, possesses unique ginsenosides (Rg3, Rg5, Rh2, Rh3, Rh4, Rs3, and F4) [@bib13], [@bib14], [@bib15].

The molecular target of ginsenosides may be located either in the cellular membrane or inside the cell, depending on the hydrophobicity of the ginsenoside [@bib16]. Most ginsenosides are lipophilic in nature; with their steroidal backbone they can traverse cell membranes by simple diffusion, and regulate cellular functions by binding to specific intracellular target proteins in the cytoplasm and nucleus [@bib16]. The nongenomic pathway of ginsenoside activity involves binding to membrane-associated receptors that initiate the activation of the phosphorylation cascade and generation of second messengers. Ginsenosides activate the genomic pathway by initially binding to intracellular nuclear hormone receptors, such as the glucocorticoid receptor, progesterone receptor, androgen receptor (AR), mineralocorticoid receptor, estrogen receptor (ER), peroxisome proliferator-activated receptor, and liver X receptor [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29]. Many studies have shown that ginsenosides act through nuclear hormone receptors. For example, one study found that administration of ginseng extract for about 1.5 wk inhibited the activity of peroxisome proliferator-activated receptor-α and the expression of several genes associated with lipid and lipoprotein metabolism [@bib30]; presumably, ginsenosides were the active constituents. Ginsenosides enhanced the expression levels of glucocorticoid receptor in the brain cytosol of heat-injured rats [@bib31]. In another study, the interaction of ginsenoside-activated glucocorticoid receptors triggered the activation of the phosphatidylinositol-3 kinase (PI3K)/Akt pathway and increased nitric oxide production in human umbilical vein endothelial cells [@bib32]. Ginsenosides act through not only steroid hormone receptors, but also ion channels. One study showed that ginsenosides inhibit voltage-dependent calcium, potassium, and sodium channel activities in a stereospecific manner, and block subtypes of nicotinic acetylcholine and 5-hydroxytryptamine type 3 receptors [@bib33].

Here, we review the ginsenosides that affect estrogen and androgen activities, including those that directly or indirectly modulate ERs and ARs. We also discuss clinical studies of ginseng on female and male reproductive functions.

2. Effects on ERα and ERβ {#sec2}
=========================

2.1. Genomic and nongenomic action {#sec2.1}
----------------------------------

Estrogens are female steroid hormones that are produced mainly by the ovaries through the conversion of cholesterol. Estrogens can also be produced locally in the placenta, adrenal glands, adipose tissue, and brain, where they act in a paracrine fashion [@bib34]. Estrogens are essential in the development and maintenance of the female reproductive system, immune system, cardiovascular system, and central and peripheral nervous systems; they also regulate bone metabolism [@bib35]. As a consequence of their wide range of physiological roles, estrogens are also involved in many pathological states, including cancer, metabolic and cardiovascular diseases, neurodegeneration, and osteoporosis [@bib36].

Phytoestrogens are compounds of plant origin that can exert estrogenic properties, through either directly binding to ER or indirectly activating ERs [@bib36], [@bib37], [@bib38]. Phytoestrogens, such as genistein and daidzein, have shown protective effects on conditions related to decreased estrogen, including menopause, osteoporosis, and cognitive disorders [@bib39], [@bib40]. The interest in the use of phytoestrogens stems from epidemiologic studies suggesting a decreased incidence of breast cancer, and lower occurrence and complaints of menopausal symptoms and osteoporosis in women from countries with high consumption of phytoestrogens, mainly found in soy products [@bib41], [@bib42], [@bib43], [@bib44].

Cellular effects of estrogens are mediated by ERs, which are transcription factors activated by ligands. Two distinct isoforms exist: ERα and ERβ. The expression patterns of these two receptors differ and display distinct characteristics. ERα is expressed mainly in reproductive tissues such as the uterus and ovary, breast, bone, white adipose tissue, and liver. ERβ is expressed mainly in the ovary, central nervous system, cardiovascular system, lung, prostate, colon, and the immune system [@bib36], [@bib45], [@bib46].

The classical estrogen action model suggests that nuclear ER changes its conformation upon ligand binding, binds to the cognate estrogen-responsive element, and modulates the transcription of target genes [@bib47], [@bib48]. Hundreds of coactivator/corepressor regulatory proteins affect the ER-mediated transcriptional response. ERs are mainly found in the nucleus and also in the cytoplasmic membrane. Estrogen binds to the membrane receptors and stimulates signaling proteins. The nongenomic pathway triggers G protein-coupled receptors, generates calcium flux, stimulates cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) production, and activates the PI3K and extracellular-signal-regulated kinase (ERK) pathways [@bib49], [@bib50], [@bib51]. Recent researches indicate that ERs were also identified in mitochondria and endosomes, and that the act of signaling from all these sites must be integrated with nuclear ER action to produce the final functions of the steroid [@bib52], [@bib53]. Studies using a xenograft model of MCF-7 human breast cancer cells injected into nude mice have shown that engagement of only the membrane receptor by an estrogenic compound failed to stimulate tumor proliferation [@bib54]. This indicates that nongenomic and genomic pathways of ER communicate, which is likely to play a role in promoting human breast tumor growth. Cellular effects of ginsenosides can be influenced by many factors, including concentration, receptor status, amount of endogenous estrogens, and target tissue [@bib55]. Some phytoestrogens display different affinities to ER isoforms [@bib56]. No study has shown antiestrogenic effects of ginsenosides, but both estrogenic and antiestrogenic activities have been reported for genistein [@bib57], [@bib58].

Treatment with *P. ginseng* upregulated both ERα and ERβ in the reproductive organs (e.g., uterus and vagina) of both normal and ovariectomized mice, demonstrating that *P. ginseng* had a potent estrogenic activity [@bib25], [@bib26]. However, *P. ginseng* upregulated the expression of ERα to a greater extent than that of ERβ in the uterus and vagina, suggesting that *P. ginseng* selectively binds to ERα in these reproductive tissues [@bib25], [@bib26]. However, ERβ antagonizes ERα-mediated effects in reproductive tissues, such as the breast, ovary, prostate, and uterus [@bib59], [@bib60]. In contrast to the effects seen in reproductive organs, treatment of immobilized mice brains and *in vitro* treatment of neuroblastoma SK-N-SH cells with hydrogen peroxide depressed ERβ, but not ERα [@bib24]. Korean Red Ginseng (KRG) upregulates ERβ and subsequently mitigates stress-induced gene expression [@bib24]. Consistently, *in vitro* studies also demonstrated that KRG represses apoptosis by potentiating PI3K/Akt signaling via ERβ upregulation [@bib61], [@bib62]. For instance, KRG appears to repress stress-induced tumor necrosis factor-α converting enzyme and nuclear factor-κB in immobilized mice brains and H~2~O~2~-induced neuroblastoma SK-N-SH cells, thus preventing the production of reactive oxygen species and protecting brain cells from apoptosis [@bib24], [@bib61], [@bib62]. Thus, in the brain, ERβ seems to inhibit apoptosis and antagonize oxidative stress.

Regarding the mechanisms of action of KRG components, the major ginsenoside Rb1 dose dependently activated both ERα and ERβ in COS monkey kidney cells, but it did not bind to the ER receptors in MCF-7 breast cancer cells [@bib63]. In contrast, the antiangiogenic effects of the ginsenoside Rb1 have been ascribed to its interaction with ERβ *in vitro*. Rb1 specifically increased the expression of a potent antiangiogenic protein pigment epithelium-derived factor by binding to ERβ, but not to ERα, resulting in the inhibition of endothelial tube formation [@bib64]. These results suggest that KRG might affect ERβ expression in a tissue- and organ-specific manner.

Reproduction is controlled mainly by estradiol in an ERα-dependent manner. Furthermore, brain functions are profoundly mediated by ERα, but not by ERβ [@bib65], [@bib66], and most research on ERβ has focused on brain function and behavior [@bib67]. However, in the brain, ERα and ERβ are usually tightly controlled in an interrelated and estradiol-dependent manner for a particular brain function [@bib67]. ERβ modulation is also common; for example, hypernatremia stress and immobilization stress downregulate ERβ expression [@bib24], [@bib68]. In contrast, *P. ginseng* may upregulate ERβ in the brain, and ERβ may counteract stress via antiapoptotic and antioxidative activities [@bib24]. Although the underlying mechanism for this effect requires further study, one possible explanation is that KRG upregulates the steroidogenic enzyme P450 (Cyp11a1) [@bib69]. Cyp11a1 catalyzes the initial and rate-limiting step in steroid hormone synthesis, and cleaves the cholesterol side chain into pregnenolone with a steroidogenic potential [@bib70]. However, an interaction between ERα and ERβ cannot be ruled out; further research on the interaction between these two proteins in the brain is therefore required to clarify the underlying mechanism.

[Fig. 1](#fig1){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"} summarizes the modulating effects of ginsenosides upon the ER pathway.

2.2. Clinical studies on menopausal symptoms, erectile dysfunction, and women\'s sexual function {#sec2.2}
------------------------------------------------------------------------------------------------

Ginseng has often been used for management of menopausal symptoms in postmenopausal women, and sexual function in both men and women. One systematic review suggested that the evidence on efficacy of ginseng for managing menopausal symptoms was limited [@bib89]. Three randomized controlled trials (RCTs), which were included in the review, tested the efficacy of KRG compared with placebo, and their results showed superior effects of KRG on sexual arousal and global health [@bib90], [@bib91], [@bib92]. Another trial reported favorable effects of ginseng supplements on well-being and depression as compared with placebo [@bib93].

Regarding the efficacy of KRG for sexual function in men, one systematic review investigated the efficacy of KRG for erectile dysfunction (ED) compared with placebo [@bib94]. This review included seven RCTs, and their results suggested superior effects of KRG on improvement of ED compared with placebo. Recently, two additional RCTs also reported positive effects of KRG on ED [@bib95], [@bib96]. Collectively, the evidence on the efficacy of KRG for treating ED is highly significant.

For the effects of KRG on women\'s sexual function, three crossover RCTs tested the efficacy of KRG for the sexual function of women compared with placebo control [@bib90], [@bib97], [@bib98]. One RCT showed positive effects of KRG on sexual arousal [@bib90], and the other two RCTs reported improvement of sexual function without statistical significance compared with placebo control [@bib97], [@bib98].

3. Effects on AR {#sec3}
================

Androgens mediate a wide range of male developmental processes, and are especially important in male sexual differentiation as well as pubertal maturation, maintenance of spermatogenesis, and male gonadotropin regulation [@bib99]. Testosterone and its metabolite 5-α-dihydrotestosterone, two principal androgens, exert their function predominately through AR-mediated pathways [@bib100]. Disorganization of the androgen--AR complex results in androgen insensitivity syndrome, eventually leading to dysfunctions of the male reproductive system, such as subfecundity or infertility. Defects in the AR lead to distinct signs of undervirilization and undermasculinization in males [@bib101]. Disturbance of the androgen--AR complex is triggered mainly by mutations in the AR gene. Mutations in the AR gene are inherited in an X-linked recessive pattern and, therefore, affect males much more frequently than females [@bib102].

Melo et al [@bib103] studied the relationship between male infertility and androgen AR mutations in Brazilian patients, and postulated that patients who do not produce sperm have a higher number of AR mutations than those with merely impaired sperm production.

While the expression level of AR itself, as well as luteinizing hormone receptor (LHR) and follicle-stimulating hormone receptor (FSHR), may also contribute to androgen insensitivity and male sub- and/or infertility, this idea has not received much scientific attention to date. This topic has largely been overlooked in the biochemical and pharmacological communities, as well as in urology. The expression levels of proteins and mRNAs for AR, LHR, and FSHR in testicular tissue from aged and doxorubicin-sensitized Sprague-Dawley rats, were significantly downregulated in these animals as well as in animals stress loaded by intermittent immobilization (2 h/d for 8 wk/6 mo) and heat (32°C, 2 h/d for 8 wk/6 mo). Pretreatment with KRG markedly prevented the downregulation of these receptors [@bib104], [@bib105]. Wang et al [@bib106], at the Center for Disease Prevention and Control in Shenyang Command, Shenyang, China, carried out a similar experiment in cold-stressed rats. They reported that ginseng polysaccharides upregulated AR mRNA expression levels and promoted testosterone. These results indicate that *P. ginseng* plays an important role in maintaining healthy levels of steroid hormone receptors, including AR, which in turn ensures the proper functioning of androgens.

4. Conclusion {#sec4}
=============

Ginseng has been used for various pathological problems, as well as for preventing and enhancing overall physiological functions. The effects of ginsengs in cancer chemoprevention and therapeutics are one of the most intensively studied areas. Identification of cellular targets responsible for such activity and characterization of active red ginseng compounds still requires continuous research. Nuclear hormone receptors are one of the cellular targets of ginsenosides that are lipophilic in nature. ER is one of the well-studied targets for ginsenosides among the members of nuclear steroid hormone receptors. Modulation of ERs by ginseng components can be beneficial to estrogen-dependent cancer and many physiological states deriving from low levels of estrogen hormones due to aging as well as inevitable ovary-related surgery in younger women. As shown, studies targeting ARs and androgen-associated physiological states are less studied. Even with accumulating data on estrogen-mimicking or supplemental activity of ginseng in humans, additional accumulative data are still required to establish and provide a scientific basis of ginseng use on sex steroid hormone-dependent function.
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Ginsenosides modulating estrogen receptor pathway

Table 1

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ginsenosides/total ginseng                                                                        Experimental model systems                                                                                                                            Observations                                                                  Signaling molecules monitored   Reference no.
  ------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------- ------------------------------- ---------------
  Total ginseng                                                                                                                                                                                                                                                                                                                                                         

   Korean Red Ginseng                                                                               SK-N-SH human neuroblastoma cells, mate ICR mice model                                                                                                Inhibits oxidative stress and apoptosis                                       PADI4, p53, Bcl-2 COX-2, ERβ    [@bib24]

  SK-N-SH human neuroblastoma cells                                                                 Antioxidant and represses apoptosis                                                                                                                   PI3K/Akt, Bcl-2, p53, Caspase-3                                               [@bib61]                        

   Radix Ginseng                                                                                    Immature Kunming mice                                                                                                                                 Estrogen effect on reproductive tissues                                       ERα, ERβ                        [@bib25]

   *P. ginseng*                                                                                     Ovariectomized mice                                                                                                                                   Can treat postmenopausal symptoms through action as an estrogen agonist       ERα, ERβ                        [@bib26]

  MCF-7 human breast cancer cells                                                                   Estrogenic activity *in vitro* but not *in vivo*                                                                                                      ERα                                                                           [@bib27]                        

  Ginsenosides                                                                                                                                                                                                                                                                                                                                                          

   Rb1                                                                                              MCF-7 human breast cancer cells, COS monkey kidney cells                                                                                              Estrogen-like activity                                                                                        [@bib63]

  Human umbilical vein endothelial cells                                                            Inhibits capillary morphogenesis                                                                                                                                                                                                    [@bib71]                        

  Ovariectomized mice                                                                               Estrogen-like effect on brain 5-HT levels                                                                                                                                                                                           [@bib72]                        

  PC12 rat pheochromocytoma cells                                                                   Prevents MPP+-induced apoptosis                                                                                                                       ERK1/2, SAPK/JNK, p38 MAPK                                                    [@bib73]                        

  Human articular chondrocytes                                                                      Anti-inflammatory and apoptotic properties                                                                                                            IL-1β, PGE2, COX-2, iNOS, Caspase-3, NO^2--^, MMP-3                           [@bib74]                        

   Rg1                                                                                              MCF-7 human breast cancer cells                                                                                                                       Proliferation                                                                 IGF-IR                          [@bib75]

  MCF-7 human breast cancer cells                                                                   Estrogen-like activity                                                                                                                                MAPK                                                                          [@bib76]                        

  Ovariectomized rat model of Alzheimer\'s disease                                                  Neuroprotective effect                                                                                                                                Caspase-3                                                                     [@bib77]                        

  Primary rat cerebrocortical neurons                                                               Neuroprotective effect                                                                                                                                ERK1/2                                                                        [@bib19]                        

  HT-22 hippocampal neuronal cells, SH-SY5Y human neuroblastoma cells, Ovariectomized rats          Promotes nonamyloidgenic cleavage of beta-amyloid precursor protein                                                                                   PI3K/Akt, MAPK                                                                [@bib78]                        

  N2a-APP694 mouse neuronal cells                                                                   Prevents memory loss                                                                                                                                  PPARγ                                                                         [@bib28]                        

  SK-N-SH human neuroblastoma cells                                                                 Apoptosis                                                                                                                                             IGF-IR                                                                        [@bib79]                        

  Bone marrow stromal cells                                                                         Proliferation, activates ER-mediated signaling                                                                                                                                                                                      [@bib80]                        

  MCF-7, MDAMB human breast cancer cells                                                            Estrogen-like activity                                                                                                                                                                                                              [@bib81]                        

   Rg3                                                                                              PC-3M prostate cancer cells                                                                                                                           Inhibits migration                                                            AQP1, p38 MAPK                  [@bib29]

  ECV304 human endothelial cells                                                                    Endothelial NO production                                                                                                                             PI3K/Akt, AMPK, JNK, p38                                                      [@bib82]                        

   Re                                                                                               Embryonic rat thoracic aortic smooth muscle cells from DBIX rat (A10 cells)                                                                           1\. Releases NO via membrane sex steroid receptors\                           PI3K/Akt                        [@bib83]
                                                                                                                                                                                                                                                          2. Promotes vasodilation\                                                                                     
                                                                                                                                                                                                                                                          3. Activates potassium channels                                                                               

  Single ventricular myocytes, MCF-7 human breast cancer cells, LNCaP human prostate cancer cells   Activates cardiac potassium channels via nongenomic pathway of sex hormone                                                                                                                                                          [@bib84]                        

   Notoginsenoside Ft1                                                                              Rat mesenteric arteries model                                                                                                                         NO-mediated relaxation                                                        PI3K/Akt, ERK1/2                [@bib20]

   Notoginsenoside R1                                                                               Endotoxemic mice                                                                                                                                      Anti-inflammation, protects the heart from septic shock                       NF-κB, I-κB, PI3K/Akt           [@bib85]

  Rat primary osteoblastic cells                                                                    Stimulates osteoblast differentiation via ER signaling                                                                                                                                                                              [@bib86]                        

   *P. ginseng* ginsenoside Rh1                                                                     MCF-7 human breast cancer cells                                                                                                                       Weak phytoestrogen                                                                                            [@bib87]

  Ginsenoside metabolites                                                                                                                                                                                                                                                                                                                                               

   Protopanaxadiol                                                                                  Primary human umbilical vein endothelial cells                                                                                                        Functional ligands for both GR and ERβ                                                                        [@bib88]

   Protopanaxatriol                                                                                 Primary human umbilical vein endothelial cells                                                                                                        Functional ligands for both GR and ERβ                                                                        [@bib88]

  AR                                                                                                                                                                                                                                                                                                                                                                    

   *P. ginseng*                                                                                     LNCaP human prostate cancer cells                                                                                                                     Inhibit AR signaling by stimulating the degradation of AR protein\            AR                              [@bib21]
                                                                                                                                                                                                                                                          Antiproliferation, apoptosis                                                                                  

  C57BL/6 mice model, human hair follicle papilla cells                                             Antiandrogen, promotes hair growth in humans                                                                                                          ERK, Akt                                                                      [@bib23]                        

   20(*s*)-25-Methoxyl-dammarane-3beta, 12beta, 20-triol (20-OCH3-PPD)                              -- *In vitro*:\                                                                                                                                       Inhibits the expression of androgen receptors, antiproliferation, apoptosis   PARP, Bax, Bcl-2, cyclin D      [@bib22]
                                                                                                    Human LNCaP (P53 wild type, androgen dependent), PC3 (P53 null, androgen independent), IMR90-EEA and IMR90-E1A human primary fibroblast cell lines\                                                                                                                 
                                                                                                    -- *In vivo*:\                                                                                                                                                                                                                                                      
                                                                                                    Prostate cancer (PC3) xenograft model                                                                                                                                                                                                                               
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AR, androgen receptor; COX-2, cyclooxygenase-2; ER, estrogen receptor; GR, glucocorticoid receptor; IL, interleukin; iNOS, inducible nitric oxide synthase; MMP-3, matrix metalloproteinase-3; NF-κB, nuclear factor-κB; NO, nitric oxide; PI3K, phosphatidylinositol-3 kinase; PPAR, peroxisome proliferator-activated receptor; 5-HT, 5-hydroxytryptamine
